Polarityte Inc (NASDAQ:COOL) CFO Paul Elliot Mann bought 20,000 shares of the company’s stock in a transaction on Tuesday, September 18th. The stock was bought at an average cost of $17.24 per share, for a total transaction of $344,800.00. Following the completion of the transaction, the chief financial officer now directly owns 120,000 shares of the company’s stock, valued at $2,068,800. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of NASDAQ:COOL traded down $0.12 on Friday, hitting $17.33. The company’s stock had a trading volume of 718,144 shares, compared to its average volume of 679,141. Polarityte Inc has a 12 month low of $15.21 and a 12 month high of $41.22. The stock has a market cap of $371.95 million, a price-to-earnings ratio of -0.65 and a beta of 1.11.
Polarityte (NASDAQ:COOL) last released its quarterly earnings results on Wednesday, September 12th. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.60) by ($0.26). The firm had revenue of $0.42 million during the quarter. Equities analysts expect that Polarityte Inc will post -3.84 EPS for the current fiscal year.
Several brokerages have weighed in on COOL. Zacks Investment Research raised Polarityte from a “sell” rating to a “hold” rating in a research report on Monday, August 27th. ValuEngine lowered Polarityte from a “buy” rating to a “hold” rating in a research report on Tuesday, June 26th. BidaskClub lowered Polarityte from a “buy” rating to a “hold” rating in a research report on Wednesday, September 5th. Finally, Cantor Fitzgerald set a $65.00 price target on Polarityte and gave the stock a “buy” rating in a research note on Wednesday, July 25th.
Polarityte Company Profile
PolarityTE, Inc engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE.
Recommended Story: How a Put Option Works
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.